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India’s EIS Officers Investigate Mysterious 
Illness Affecting Children in Muzaffarpur 
Submitted by: Dr. Kayla Laserson, Resident Advisor, India EIS Program 
In May 2013, India’s first Epidemic Intelligence Service (EIS) class of 7 officers travelled to Muzaffarpur district in the 
state of Bihar in northeast India.  They went to 
investigate a recurrent outbreak of an unknown 
acute neurological syndrome (ANS) that causes 
swelling of the brain and seizures and can lead 
to death within hours of disease onset. There 
have been previous large outbreaks of ANS in 
Muzaffarpur in 2005, 2011 and 2012 affecting 
hundreds of young children. The outbreaks  
consistently occurred during the dry, hot 
months of May and June and  primarily affected  
young children (2-5 years) who had seizures 
and/or altered mental status; 35-44% of the 
children died.  This year there were 130 cases 
and 59 deaths.
This part of India is the primary litchi (lychee 
fruit) growing area in the country. The peak of 
the outbreak has been noted to coincide with 
the litchi harvesting season, which has led to 
various hypotheses regarding associations 
between consumption or contact with litchis 
and the development of this acute neurologic 
illness. These potential associations have not 
been confirmed.  Every year, the number of ANS 
cases declines dramatically with the onset 
of the monsoon weather and rains.  A link 
among the cases has not been identified; 
each affected child in the last several years 
has been an isolated case in his or her village. 
Children affected are neither the youngest nor 
the oldest in their household. Almost all  cases 
reside in rural sections of Muzaffarpur district, 
while very few patients are from urban centers.
During this year’s outbreak, from May 17-July 
21, the India EIS officers, under the direction 
of the India National Center for Disease 
Control (NCDC) of the  Ministry of Health and 
Family Welfare, in collaboration with the U.S. 
CDC’s Global Disease Detection Center in 
India, conducted prospective hospital-based 
surveillance for ANS at three referral hospitals 
in Muzaffarpur district. Identified ANS cases 
were enrolled in a nested case-control study 
to evaluate potential risk factors for illness and 
mortality.  
The NCDC-led investigation was also assisted 
by CDC experts in Atlanta.  Each Indian EIS 
officer spent at least 6 weeks on site, enrolling 
cases in surveillance, and enrolling cases 
Several EIS officers and health authorities from Muzaffarpur 
District and Dr. Jim Sejvar, the CDC Neuroepidemiologist 
who came to assist with the outbreak investigation, discussing 
the outbreak.
EIS officer Dr. Kapil Goel interviewing the mother of a 
child with ANS in Muzaffarpur District, India.
Continued on page 2
Seeking Submissions…
If you would like your program to 
be featured in an upcoming issue of 
Updates from the Field, please send 
a 200-400 word summary of your 
program’s activities and photos to 
Ruth Cooke Gibbs at icn6@cdc.gov.
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Highlights of Investigations
An Up Close Look at Nipah Virus in Bangladesh
Submitted by: Sonia Hegde, MPH – ASPH Fellow, CDC Atlanta 
As a second-year Association of Schools of Public Health (ASPH) Global Epidemiology fellow, I have spent                approximately one year in Bangladesh, working with 
CDC’s Global Disease Detection Center and leading a study of 
risk factors for infection by Nipah virus: a disease that causes 
encephalitis and severe respiratory distress and has a case fatality 
rate over 75% in Bangladesh. On a particular field visit for Nipah 
virus surveillance, a Bangladeshi medical epidemiologist and I 
finally reached the remote hospital where we sought to evaluate 
a patient with encephalitis. We found him: an unconscious boy, 
held in his mother’s arms, saliva foaming at his mouth. His lips 
moved ceaselessly, mouthing silent screams of pain. We would 
not know for days whether his blood sample would test positive 
for Nipah virus. I carried out my investigative tasks: identifying 
his latest contacts, activities, approximate onset of illness, 
and possible exposures. I used the tools I was given to better 
understand his condition and to inform measures of prevention 
for this distressing encounter.
Experiences like this bedside visit helped me to not only see the 
human face of the disease I was approaching as a public health 
problem, but also the practicality and usefulness of epidemiology. 
Intellectually, I knew that the scientific study that brought me to 
this child’s bedside was important, that in the fullness of time it may 
alleviate the suffering not only of one patient, but could bring relief 
to many. But I also discovered that I couldn’t address this sort of 
suffering as scientific inquiry alone; that we must master the art of 
caring and truly understanding another’s condition so that we may 
one day better address the complexity of human needs. I looked at 
this Bangladeshi boy not as study material, but rather as a child in 
agony, the alleviation of whose pain is the greatest need in the world 
and whose pain we, as a scientific community, are working to prevent.
For further information, please contact Dr. Jeremy Sobel  at 
qzs2@cdc.gov.
A young boy with Nipah virus is receiving supportive care. There are currently no drugs 
or vaccines available to treat Nipah virus infection.
A hospital waiting area is lined with people suffering from Nipah virus infection.
A young child with Nipah virus is receiving supportive care. There are currently no 
drugs or vaccines available to treat Nipah virus infection.
India’s EIS Officers Investigate Illness 
continued from page 1
and controls (both hospital and community) in the case control 
study.  The teams collected demographic, clinical and exposure 
information from the study participants, and collected specimens 
from participants for testing for infectious diseases such as Japanese 
Encephalitis , West Nile virus, Nipah, Chandipura, and enteroviruses. 
To date, the cause for this illness has not been confirmed.  
The Indian EIS officers will participate in data analysis, 
interpretation and dissemination of results. The EIS officers were all 
excited to have been part of this important investigation, learned a 
systematic approach to outbreak investigation, and will apply these 
skills to future investigations.
For further information, please contact Dr Padmini Srikantiah 
(pks6@cdc.gov), CDC India.
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Highlights of Investigations
A John Snow Moment in a Small Rural Village in Vietnam
Submitted by: Dr. Alden Henderson, CDC Atlanta 
During the 1840s and 1850s, a series of cholera outbreaks occurred in London and people thought that the outbreaks were caused by miasma or “bad air”.  John Snow, an 
anesthesiologist who is now considered one of the fathers of modern 
epidemiology, talked to local residents and traced the source of the 
outbreak to a water pump on Broad Street, London.  Snow used a dot 
map to show clusters of cholera around the pump. He also used statistics 
to show that the public works delivered sewage-polluted water from 
sections of the Thames River to homes near the Broad Street pump 
where the highest incidents of cholera occurred.   Despite not knowing 
the exact cause of the outbreak, Dr. Snow presented his theory to city 
officials and the next day, the pump handle was removed. This action 
helped end the cholera epidemic in London.  Last year, a similar event 
involving a disease of unknown etiology occurred in Ba Tơ, a small rural 
village in Central Vietnam.
In April 2012, newspapers reported 164 people 
had a mysterious skin disease that caused 8 
deaths.  Symptoms of the disease began with a 
rash on the hands and feet and in some patients, 
it caused liver damage and multiple organ 
failure.   Several investigations were unable to 
find the cause of this disease.  
In June of 2012, the Vietnam Ministry of Health 
conducted an intensive investigation that 
examined infectious and environmental causes.  
Residents from the Vietnam Field Epidemiology 
Training Program (FETP) were asked to conduct 
an epidemiological study to help understand the 
cause of the disease.
The epidemiological study reported a strong 
association with eating rice from the previous 
harvest.  According to Vietnam FETP Resident 
Advisor, Tran Minh Nguyen, “We did not know 
if the cause of this disease (now called IPPH -  
idiopathic palmar-planter hyperkeratitis) was the 
poor nutritional content of the  rice or a poison 
or toxin in the rice.  However, we felt that the rice 
was contributing to the disease because people 
who ate the rice were fifteen times more likely to 
become ill.”  
As a result of this information, in August 2012, the Government 
of Vietnam began to provide rice and vitamin supplements to the 
residents of Quang Ngai and to date, very few new cases of IPPH 
have occurred.  The Vietnamese government continues to monitor 
the situation in Quang Nai and bordering villages.  With the hope of 
finding the exact cause of IPPH and preventing future outbreaks, the 
Vietnam-FETP continue to test rice for fungi and toxins caused by 
fungi and  nutritional content.
For further information, please contact Dr. Alden Henderson 
akh0@cdc.gov
A Vietnamese patient with IPPH lesions on his foot.
A Vietnamese physician examining a family with IPPH.
A Vietnamese patient with IPPH lesions on his foot.
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Partnership Matters
Thailand’s International FETP Launches Thailand-Burma 
Cross-border Surveillance Evaluation
Submitted by: Dr. Tippavan Nagachinta and Dr. Alden Henderson, CDC Atlanta  
Since the revised International Health Regulations were put into place in 2005, ministries of health around the world 
are working collaboratively with WHO and 
other partners including CDC to strengthen 
their ability to have robust disease surveillance 
systems. These systems are critical to enabling 
countries to identify public health threats, 
provide rapid response, and control and 
prevent future outbreaks. 
After outbreaks of Severe Acute Respiratory 
Syndrome (SARS) in 2002 and H5N1 influenza 
in 2003, Thailand’s International FETP (IFETP), 
in collaboration with neighboring countries, 
established cross-border surveillance and 
outbreak response activities in 2009 and 
now conducts cross-border surveillance 
investigations with neighboring countries (Laos, Cambodia, 
Vietnam, and Malaysia). Several cross-border surveillance 
investigations have been conducted shortly after the new cohort of 
IFETP residents complete their first 4-weeks of didactic training.  
Malaria is endemic between the borders of Thailand and Burma 
and presents a concern of antimalarial drug resistance to the 
Thai Ministry of Public Health (MOPH) due to high mobility of the 
migrant population near the border. In June 2013 two Burmese 
medical officers supported by the U.S. President’s Malaria Initiative 
participated in the IFETP and proposed an evaluation of malaria 
surveillance in the border region. In July, Thailand  IFETP launched 
the Burma-Thailand cross-border surveillance evaluation of malaria 
at Mae Sot Hospital, Tak Province, Thailand and Myawaddy District 
Hospital, and a few rural health centers in Myawaddy, Kayin State, 
Burma. Three IFETP residents (2 from Burma and 1 from Vietnam) 
participated in this activity together with a team from the Thailand 
IFETP which consisted of Thai FETP training instructors and 
graduates, and local public health staff. 
The three IFETP residents reviewed data from the two hospitals 
in the border region. All available surveillance data on malaria 
from 1999-2012 were collected from the hospitals. IFETP 
residents analyzed the data according to the CDC guidelines 
for conducting a surveillance evaluation.  The findings obtained 
from this surveillance evaluation were presented to health 
officials and international visitors on July 19, 2013. A plan to 
improve surveillance systems in both hospitals was presented 
with open discussion. 
This international collaboration on surveillance activities 
indicates a strong partnership between the ministries of health 
in Thailand and Burma to strengthen the capacity of disease 
surveillance systems in both countries. Lessons learned from 
this cross-border activity will also improve the training program 
in field epidemiology and strengthen the cooperation and 
collaboration between the two countries to conduct future 
disease outbreak investigations together.
For further information, please contact: Dr. Tippavan 
Nagachinta at txn3@cdc.gov.
Thai-Burmese FETP investigation team and Burmese public health officials at the Thai-Burmese surveillance 
meeting in Mae Sot, Tak Province, Thailand, July 19, 2013.
Thai-IFETP resident interviewing Myawaddy hospital staff during malaria surveillance 
evaluation, July 16, 2013.
Team members interviewing Mae Sod Hospital epidemiologist, July 16, 2013. 
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Partnership Matters
Officials from South Africa’s National Department of 
Health and National Treasury meet with CDC about 
National Public Health Institute Development
Submitted by: Shelly Bratton, CDC Atlanta 
CDC South Africa is working closely with the South African National Department of Health 
(NDOH) to strengthen its public health 
surveillance, epidemiology, outbreak 
response and public health workforce. 
The South Africa government is 
specifically focusing on public health 
priorities in the areas of communicable 
diseases, non-communicable diseases, 
cancer surveillance, injury and violence 
prevention, and occupational health 
and safety. 
From August 19-23, a delegation of 
South African government officials 
and CDC South Africa staff visited CDC 
in Atlanta to better understand how 
national public health institute (NPHI) 
models are structured to maximize 
public health impact.  CDC’s Division of Global Health 
Protection (DGHP, proposed) coordinated the visit 
in partnership with the International Association of 
National Public Health Institutes (IANPHI). With funding 
from the Bill and Melinda Gates Foundation, CDC 
and IANPHI are working together to help countries 
develop or strengthen NPHIs. South Africa’s exploration 
of potential policy options for an NPHI is also being 
funded through the Gates Foundation. 
The South African team participated in seminars and 
meetings with senior CDC experts from across the 
agency to learn about the agency’s history, governance, 
legislative authorities, innovative programs for disease 
prevention and outbreak response, and coordination 
mechanisms at CDC, the U.S. Department of Health 
and Human Services, and state health departments. In 
addition, the delegation learned about CDC’s ability to leverage 
the private sector through public-private partnerships and the 
CDC Foundation. They also heard from IANPHI experts on the 
various models for NPHI development and organization based 
on the experience of IANPHI’s >90 members. A senior official 
from the Public Health Agency of Canada, a key CDC and IANPHI 
partner, provided insights into how her agency was created 
following the SARS epidemic in 2003.  
As a result of the visit, the team identified potential quick 
actions to improve public health upon returning to South Africa, 
including working with partners to improve coordination of 
surveillance and TB control. According to Dr. Kistnasamy, “Our 
time in Atlanta helped us think through some of the challenges and 
opportunities we face and identify innovative ways to improve public 
health in South Africa.  We are very grateful for our time with experts 
from CDC, IANPHI, the Georgia Department of Health, and the Public 
Health Agency of Canada and look forward to building upon these 
relationships as we move forward to enhance the health of all who 
live and work in South Africa.”
For further information, please contact: Shelly Bratton at bwp8@
cdc.gov.
August 21, South Africa delegation, CDC, and IANPHI meet with Dr. Theresa Tam from Public Health Agency of 
Canada. Back row, l-r: Goolam Manack, Allison White, Dennis Jarvis, Frew Benson, Shabir Madhi, Barry Kistnasamy; 
Front row, l-r: Shelly Bratton, Heidi O’Bra, Theresa Tam, Sue Binder, Rachel Eidex, Nancy Knight, and Mike St. Louis. 
Photo courtesy of Ken Johnson. 
South Africa delegation meets with CDC Director, Dr. Thomas Frieden at CDC 
Headquarters in Atlanta, Georgia. From l-r: Frew Benson (NDOH), Goolam Manack 
(National Treasury), Dr. Frieden (CDC), (not visible) Barry Kistnasamy (NDOH), 
(head turned) Nancy Knight (CDC). Photo courtesy of  Amanda J. Mills.
www.cdc.gov/globalhealth Updates from the Field: Fall 2013, Issue 12 6 of 9
Partnership Matters
WHO/HHS Workshop on Enhancing Communication 
around Influenza Vaccination Atlanta, CDC Tom Harkin 
Global Communications Center 
Submitted By: Marie-Paule Kieny*, Daniel Miller§, Asiya Odugleh-Kolev*, Claudia Nannei* and Alexandra Ganim§
The Workshop on Enhancing Communication around Influenza Vaccination was held at CDC June 
11-13, 2013 and was attended by more 
than 90 participants from 31 countries, 
representing national governments, vaccine 
manufacturers, healthcare professional 
associations, journalists and development 
partners. The objectives of the workshop 
were to: 
 • bring together key stakeholders to 
identify and discuss common concerns 
and challenges in communicating 
the importance and benefits of 
seasonal influenza vaccination, address 
misinformation and promote vaccine 
acceptance by health professionals and 
the public; 
 • provide a forum to discuss evidence-based 
mechanisms, best practices and effective 
models for strengthening national and 
regional communication capacities for 
influenza vaccination, including innovative 
use of media tools; and  
 • define national and regional priorities and 
options for building sustainable communication 
capacity for seasonal influenza and pandemic preparedness.
Positioned within the context of the World Health Organization’s 
(WHO) Global Action Plan for Influenza Vaccination (GAP), the 
agenda flowed from expert opinion to reflection and discussion 
on the key topics covered. Presentations provided a background 
for: understanding the context; clarifying myths and facts; 
exploring vaccine refusal and confidence; uncovering specific 
communication assumptions; discovering communication 
science; and sharing lessons learned on capacity building 
experiences. The break-out sessions enabled in-depth discussions 
among participants and led to an agreement on common 
obstacles, success factors and recommendations for establishing 
an effective communication system in any country.
The outcome of the workshop was the establishment of a model 
for an effective national communication system to routinely 
develop and execute appropriate and relevant context-specific 
national communication plans and strategies for seasonal and 
pandemic influenza.  The full workshop report, which will provide 
more detail about the development of this framework and insight 




The Workshop on Enhancing Communication around Influenza 
Vaccination is part of a series of workshops organized  by the 
U.S. Department of Health and Human Services (HHS) Office 
of Global Affairs and WHO Health Systems and Innovation 
Cluster to support the GAP and global influenza pandemic 
preparedness. The GAP promotes the expansion of influenza 
vaccine production capacity, including the establishment of new 
production facilities in countries and regions previously lacking 
capacity to ensure rapid and equitable access to influenza 
vaccines in the event of a pandemic. It also promotes evidence-
based national policy development to increase access, up-take 
and use of influenza vaccines and research for the development 
of better influenza vaccines. 
*World Health Organization
§US Department of Health and Human Services
Diagram 1: Building blocks for an effective national communication framework to improve to improve 
and strengthen seasonal and pandemic influenza. 
www.cdc.gov/globalhealth Updates from the Field: Fall 2013, Issue 12 7 of 9
Disease Discovery
CDC Identifies a Novel Poxvirus in Georgia, July 2013
Submitted by: Dr. Juliette Morgan, Dr. Mary Reynolds and Justin Williams, CDC 
The U.S. Centers for Disease Control and Prevention (CDC) is coordinating with the National Center for Disease Control and Public Health of Georgia (NCDC) to investigate the 
discovery of a new Poxvirus that so far has affected two individuals.
On July 5, 2013, the U.S. CDC’s Global Disease Detection Center 
in Tbilisi, Georgia was contacted by personnel from the NCDC 
requesting assistance in diagnostic evaluation of a shepherd 
suspected of having cowpox. Cowpox is caused by a virus which 
belongs to the family of Poxviruses. These viruses can cause 
disease in domestic animals such as cows and sheep, which 
can be transmitted to humans by direct contact with infected 
animals such as skin exposure to infected udders during milking. 
The human disease can be confused with cutaneous anthrax 
(anthrax that enters the body through cuts or sores in the skin). 
The shepherd was 
evaluated clinically 
by a local physician 
and later referred to 
an infectious diseases 
hospital where 
biological samples 
were collected after 
consultation with CDC 
experts in Atlanta. 
Two weeks later, a 
second shepherd from 
the same district—a 
close contact of the 
first— presented with 
a similar illness. 
Clinical specimens 
were collected from 
the second shepherd and both sets of specimens were shipped 
to the Poxvirus laboratory at CDC in Atlanta. Both shepherds 
reported, prior to becoming ill, having had direct contact with 
cows that had pox lesions on their udders. Each summer both 
shepherds take their cattle to graze in the foothills of the Caucasus 
Mountains near the border with Russia.
The specimens arrived at the U.S. CDC Poxvirus laboratory on July 
18, and the tests confirmed the presence of a virus belonging to 
the family of Poxviruses in the genus Orthopoxvirus, however 
the virus was found to be very different from other characterized 
Orthopoxvirus species. The Orthopoxvirus genus includes viruses 
that can cause severe illness and death, such as the smallpox virus 
(variola) which was eradicated through an effective program of 
surveillance, containment and vaccination. 
The discovery of a new poxvirus is notable for several reasons.
 • As a new virus, it is not adequately captured by current rapid 
diagnostic tests, therefore new tests need to be developed to 
identify this new poxvirus.
 • The medical and epidemiologic features of these poxvirus 
infections have not been defined.
 • Potential impacts to agricultural production and risks to 
agricultural workers need to be defined.
CDC-Georgia is coordinating the investigation with subject 
matter experts from the CDC’s Poxvirus and Rabies Branch*, and 
with experts from NCDC, to:
 • lead the human case investigation, including interviewing the 
shepherds and conducting active human case finding;
 • train Georgian staff on lab tests and transfer appropriate 
technology to the Lugar Center in Georgia. The Lugar Center is 
a cooperative laboratory effort between the U.S. and Georgian 
governments;
 • search for the source of the virus among local animals;
 • brief relevant staff and reach consensus on the investigation 
approach with NCDC and the Ministry of Agriculture’s 
National Food Agency and National Laboratory;
 • engage the National “One Health” Task Force who will 
participate in the field work;
 • involve graduates from the U.S. CDC Tbilisi Field Epidemiology 
and Laboratory Training Program (FELTP) in the health and 
agricultural sectors of the investigation; 
 • strengthen laboratory-based surveillance activities; and
 • measure the agricultural impact.
Due to the support of the CDC Global Disease Detection 
Center in Georgia, CDC subject matter experts, and the close 
U.S. Government collaboration with NCDC, as demonstrated 
through these ongoing efforts to investigate this novel virus, 
emerging and re-emerging diseases can be quickly detected 
and comprehensive strategies put in place to prevent illness and 
save lives.
* The Rabies and Poxvirus Branch is in CDC’s National Center 
for Emerging and Zoonotic Infectious Diseases/Division of High 
Consequence Pathogens and Pathology.
For further information, please contact Dr. Juliette Morgan, 
jtm7@cdc.gov.
CDC orthopox expert Darrin Carrol along with a local 
mammologist dissecting a rodent in a field lab designed to 
test for orthopox. Photo by Giorgi Turabelidze. 
Georgian regional veterinarian and a local shepherd, getting a sample from a 
previously symptomatic cow, to test for the novel orthopox virus.
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Graduate Corner   
The Haiti Field Epidemiology Training Program (FETP) 
Graduates its Second Cohort
Submitted by: John Ngulefac, CDC Atlanta
In the wake of the earthquake and subsequent outbreak of cholera, it quickly became clear that epidemiological support for Haiti’s Ministry of 
Public Health and Population (MSPP) was needed.  
Enhancing MSPP’s response to future outbreaks 
includes strengthening the collection and evaluation 
of surveillance data, and enhancing response to 
possible outbreaks of disease. 
A little over a year after the earthquake, CDC through 
support from the Health Systems Reconstruction 
Team within CDC’s Emergency Response and 
Recovery Branch began identifying and screening 
candidates for the Haitian Field Epidemiology 
Training Program (FETP), which mirrors CDC’s 
Epidemic Intelligence Service program. It utilizes a 
three-tiered structure with a curriculum tailored to the 
resident’s work functions at the local, departmental, and 
national levels of government. 
On July 24th, 2013, Haiti celebrated the graduation of 
eleven residents from the nine-month intermediate level 
of Haiti’s three-tiered FETP. The graduation ceremony was 
attended by more than 40 participants from MSPP and 
CDC. Speakers included the Director General of  Haiti’s 
MSPP, Dr. Guirlaine Raymond Charité, the CDC-Haiti 
FETP technical advisor, Dr. Nadia Phaimyr Jean Charles 
and speakers from both CDC Haiti and CDC 
Atlanta. During her speech, the Director 
General stated: “This training is important 
in the eyes of the highest authority of the 
Ministry when we consider the role that 
epidemiological surveillance must play 
in the improvement of the population’s 
health.  This training meets a need….to 
strengthen epidemiological surveillance 
developed by DELR with the support of its 
partners…”
During the ceremony, Dr. Andrecy Lesly 
Liverdieu, president of the graduating class, 
thanked the Haitian and U.S. governments 
for accepting them into the program and 
for providing funding for their participation. 
On behalf of his classmates, he promised their readiness, 
pledged themselves to be the ambassadors of the program, and 
re-affirmed their willingness to improve public health in Haiti.
The graduates received their diploma after nine months of 
intensive class and field work. The residents have worked 
on several activities including surveillance, outbreak 
investigations, and scientific studies.  They also submitted 
abstracts to international conferences. Recently, the Haiti FETP 
residents played a critical role in confirming and containing a 
cholera outbreak in Croix-des-Bouquets, a locality in the West 
Department.
With the graduation of these eleven residents, the three-tiered 
Haiti FETP program has now trained 60 public health leaders in 
basic level and 23 residents in the intermediate level. 
For further information, please contact Dr. Nadia Phaimyr Jean 
Charles at xfg6@cdc.gov.
Director General of  Haiti’s MSPP, Dr. Guirlaine 
Raymond Charité providing remarks during the 
Haiti-FETP graduation ceremony, July 24, 2013. Haiti-FETP residents responding to a cholera 
outbreak in Haiti in February, 2013. 
FETP Coordinator, Dr Patrick Dely providing 
remarks during the Haiti-FETP graduation 
ceremony in Port-au-Prince, Haiti, July 24, 2013.
Dr. Roc Magloire, Director of the Direction of 
Epidemiology, Laboratory and Research (DELR) 
providing remarks during the Haiti-FETP 
graduation ceremony, July 24 ,2013. 
Haiti-FETP Cohort 2 graduating class of 2013.
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Training and Resources
IDSR Training in the Democratic Republic of Congo 
Embraces the One Health Approach to Public Health
Submitted by: Monique Tuyisenge-Onyegbula, CDC Atlanta
For more than a decade, Member States within the World Health Organization (WHO) Regional Office for Africa (AFRO) have been implementing the Integrated Disease Surveillance 
and Response (IDSR) strategy for improving their public health 
surveillance and response  systems.  IDSR targets the leading causes 
of illness, death and disability, and is designed to strengthen the 
linkages for detecting, confirming and responding to disease 
threats at community, health facility, district and national levels.  
The Democratic Republic of Congo (DRC) is one of the 47 AFRO 
Member States that has been implementing the IDSR strategy 
and has also adapted and adopted the revised IDSR Technical 
Guidelines  which countries use as a reference for policy, processes 
and training development and incorporates the expanded scope 
of the International Health Regulations (IHR 2005).  The goal of 
the DRC’s Direction de Lutte Contre la Maladie (DLM) (Department 
for Disease Control) is to have an operational and strong disease 
surveillance system for timely detection and response to the 
leading causes of illness, death and disability in the country.  
In July, 2013, IDSR and Field Epidemiology 
Training Program teams from the Centers 
for Disease Control and Prevention (CDC)’s 
Division of Global Health Protection 
(proposed) were invited to conduct an 
IDSR training in Kinshasa in collaboration 
with DRC’s DLM using the French language 
version of the revised IDSR Technical 
Guidelines and training materials.  The 
training was facilitated by Monique 
Tuyisenge-Onyegbula from CDC’s Global 
Health Security Branch, John Ngulefac from 
CDC’s Field Epidemiology Training Program 
Branch (FETPB) and Dr. Yassa Daniel, DRC’s 
FELTP Resident Advisor.  The participants 
in the course came from  several ministries 
including the Public Health, Animal Health, 
Environment and Conservation ministries, as 
well as from the Congolese Armed Forces and Interior (Congolese 
National Police) ministries. 
The training incorporated the goal of the One Health approach 
to increase collaboration across disciplines and improved 
understanding and response to a range of health issues. DRC 
frequently suffers from cycles of conflict and violence by armed 
groups.  Training the police force in IDSR objectives about disease 
priorities, reporting, data thresholds and response, extends these 
critical capabilities to civilian populations not served by public 
health programs. Often, in hard-to-reach and post-disaster areas in 
the DRC, the police are more able to access or are already present 
in these areas and can contribute to more timely detection and 
reporting of public health threats.  Dr. Kebella Ilunga Benoit, 
Director of DRC’s DLM remarked, “During a recent Ebola outbreak 
in Isiro, civilian doctors from the DLM did not have access to 
patients in parts of the country, so information and samples were 
transported to National Reference laboratories via the police and 
military doctors who were deployed to the areas. ” Dr. Yassa Daniel 
added that “when you train the military and police force of a 
country, you have actually trained the community”.
For further information, please contact Monique Tuyisenge-
Onyegbula at von8@cdc.gov.
From left: Dr Wat’senga Laya of the Congolese National Police, John Ngulefac of 
FELTP, CDC, Dr Sudiakonga Djonga of the Congolese National Police and Monique 
Tuyisenge-Onyegbula of IDSR, CDC. Photo courtesy of Monique Tuyisenge-Onyegbula.
Dr. Kebella Ilunga Benoit, DRC’s Director of Disease Control (la Direction de Lutte Contre 
la Maladie (DLM) presenting the main findings and recommendations of an investigation 
of a recent Ebola outbreak in Isiro. Photo courtesy of Monique Tuyisenge-Onyegbula
IDSR training attendees, July 1-5, 2013 at the Blood Transfusion Center, Kinshasa, DRC. Photo courtesy of 
Monique Tuyisenge-Onyegbula. 
